KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Common Equity (2016 - 2026)

Fulgent Genetics' Common Equity history spans 12 years, with the latest figure at $1.0 billion for Q1 2026.

  • On a quarterly basis, Common Equity fell 6.5% to $1.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.0 billion, a 6.5% decrease, with the full-year FY2025 number at $1.1 billion, down 1.52% from a year prior.
  • Common Equity hit $1.0 billion in Q1 2026 for Fulgent Genetics, down from $1.1 billion in the prior quarter.
  • Over the last five years, Common Equity for FLGT hit a ceiling of $1.3 billion in Q1 2022 and a floor of $1.0 billion in Q1 2026.
  • Historically, Common Equity has averaged $1.2 billion across 5 years, with a median of $1.1 billion in 2023.
  • Biggest five-year swings in Common Equity: surged 63.8% in 2022 and later fell 11.21% in 2024.
  • Tracing FLGT's Common Equity over 5 years: stood at $1.3 billion in 2022, then fell by 10.76% to $1.1 billion in 2023, then fell by 0.36% to $1.1 billion in 2024, then decreased by 1.52% to $1.1 billion in 2025, then dropped by 5.59% to $1.0 billion in 2026.
  • Business Quant data shows Common Equity for FLGT at $1.0 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.